This Web Site is committed to the memory of Janis Morrow.
INDEX :HCV BLOOD TESTS/Labs
|
Page One: |
||||||||||
|
Great Place
to look up your test results :
|
||||||||||
|
Page Two: |
||||||||||
|
Overall view |
||||||||||
|
Page Three:
|
||||||||||
|
Page Four: |
||||||||||
|
|
||||||||||
|
What does it all
mean? (Interpreting Liver function tests)
Page Five: Formation of Blood Cells ,Red Blood Cells ,Oxygen Transport Carbon Dioxide Transport , Anemia , Blood Groups ,White Blood Cells , Lymphocytes , Monocytes , Neutrophils Eosinophils , Basophils Platelets, Plasma , Serum , Proteins Serum ,Lipids On This Page: ALT Predicts Mortality & General Health - Understanding Log Changes in your Viral Load ( What is a 2 log Increase or Decrease ? |
||||||||||
Elevated ALT and AST Predict Higher Mortality in General Population Elevated levels of the liver enzymes alanine and aspartate aminotransferase (ALT and AST) are associated with a greater 10-year risk of death in the general population, regardless of presence of viral hepatitis or other known liver disease, according to a study presented last month at the American Association for the Study of Liver Diseases (AASLD) annual meeting in Boston. Researchers from the Mayo Clinic in Rochester, MN, analyzed data from all community residents who had their ALT or AST measured during 1995. Subjects were followed forward and their survival was determined. In order to exclude patients with abnormal liver function tests due to pre-existing terminal illness, deaths within the first 2 years were excluded. Results
Conclusion At the conference, AASLD launched a public education campaign recommending that Americans pay more attention to ALT as an important marker of liver health and disease -- especially as levels of obesity rise and more people develop fatty liver disease. The association also urged the recalibration of what is considered normal ALT to reflect levels in individuals with healthy livers. Existing so-called "normal" references ranges may be based on populations that include apparently healthy individuals with unrecognized liver disease related to the metabolic syndrome, fatty liver, use of alcohol or toxic drugs, or undiagnosed viral hepatitis. According to AASLD, persistently elevated ALT should always be further evaluated for a cause, given that too many practitioners currently ignore minor elevations in asymptomatic individuals. Diagnosis of liver disease at early, more treatable stages is crucial, not least due to the dire shortage of donated livers for transplantation. Further, the organization stated, "ALT is not only an indicator of liver disease but also a gauge of general health, as there is a strong relationship between ALT activity and mortality, even when the life-threatening process does not originate from the liver." AASLD intends to promote ALT as a routine indicator of overall health, similar to cholesterol or blood pressure. 11/14/06
Reference http://www.hivandhepatitis.com/2006icr/aasld/docs/111406_d.html
TWO New Tests to detect Fibrosis ; 2007 Non-Invasive and Inexpensive Fibrosis Evaluation for HCV Comparison of 6 Non-invasive Measures for Diagnosing Liver Fibrosis in Hepatitis C Patients New Index for Assessing Liver Fibrosis Battle of the New, Non-invasive Measures of Fibrosis: FibroScan versus FibroTest Feb 21 2006 Sep 02 2005
|
||||||||||
|
Prometheus
Laboratories Introduces Non-Invasive Test for the Detection of Liver Fibrosis
FIBROSpect
|
||||||||||
|
LabCorp® Announces U.S.
Launch Of Exclusive Liver Fibrosis Assay HCV Fibrosure™
|
||||||||||
|
|
||||||||||
|
|
||||||||||
| Viral Load Test | ||||||||||
|
Quest
Diagnostics Announces Availability of HEPTIMAX Ultra-Sensitive Quantitative
Hepatitis C Virus Test |
||||||||||
| Understanding Log Changes in your Viral Load | ||||||||||
|
|
||||||||||
|
|
||||||||||
|
Found on our Biopsy Pages : |
||||||||||
| Original HAI (Histology Activity Index), the Modified HAI, and the Metavir. |